BioPharma Credit PLC (MUN:B3P)

Market Cap	904.58M +6.2%
Revenue (ttm)	134.35M +5.1%
Net Income	110.62M +6.3%
EPS	0.10 +14.0%
Shares Out	n/a
PE Ratio	8.18
Forward PE	n/a
Dividend	0.08 (10.66%)
Ex-Dividend Date	Apr 30, 2026

Volume	200
Average Volume	3,285
Open	0.7750
Previous Close	0.7950
Day's Range	0.7550 - 0.7950
52-Week Range	0.7500 - 0.8700
Beta	n/a
RSI	n/a
Earnings Date	Mar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: Munich Stock Exchange
• Ticker Symbol: B3P

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD